Leuprolide inj - UMMC
Leuprolide inj - UMMC
Leuprolide inj - UMMC
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
• congestive heart failure or other conditions requiring sodium restriction<br />
• depression<br />
• history of thromboembolism or cardiovascular disease<br />
• increased risk of spinal cord compression<br />
• metastatic vertebral lesions<br />
• occurrence of memory disorders<br />
• transient worsening of prostate cancer symptoms (increased testosterone serum<br />
level)<br />
• undiagnosed abnormal vaginal bleeding<br />
Special notes • Lucrin 3.75mg is used monthly and 11.25mg is used three monthly<br />
• Goserelin or leuprolide has been approved for FOC supply to Government<br />
servants / dependants for treatment of CA prostate. (D&T Bil 5/2006 dated 13 Nov<br />
2006)<br />
• <strong>Leuprolide</strong> approved for 20 children / year to receive FOC supply for treatment<br />
of precocious puberty. Prescription must be written by Paediatric Endocrinologist.<br />
(D&T bil 1/2007 dated 12.1.2007)<br />
Patient Information Possible Side Effects: Increased bone pain, weakness, burning, or tingling of legs or<br />
feet, eecrease in how much or how often you urinate<br />
Prepared/checked by Tan Ching Hooi / PDS / HKD / PL<br />
Date compiled/edition 9 June 2008, 1 st edition
Change language